CTOs on the Move

Kaleido Biosciences

www.kaleido.com

 
Kaleido Biosciences is a clinical-stage biotechnology company engaged in the development of novel chemistries that unlock the power of the microbiome to revolutionize health. The Company has built the first R&D engine to systematically create, discover, and develop interventions that activate metabolic processes in the microbiome to treat disease and maintain health. Since its founding in 2015 by Flagship VentureLabs, Kaleido has advanced candidate products into clinical studies across programs in rare genetic diseases, oncology and infectious disease, and has generated more than 3,000 days of human clinical data. The Company is also creating consumer products that optimize the microbiome`s ...
  • Number of Employees: 100-250
  • Annual Revenue: $1-10 Million
  • www.kaleido.com
  • 18 Crosby Drive
    Bedford, MA USA 01730
  • Phone: 617.674.9000

Executives

Name Title Contact Details
Stephen Sofen
 Senior Vice President of Technical Operation Profile

Funding

Kaleido Biosciences raised $60.4M on 02/04/2021

Similar Companies

Lenetix Inc

Lenetix Inc is a Mineola, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Jencons

Jencons is a Bridgeville, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Health Advocacy Solutions

Health Advocacy Solutions is a Portland, OR-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

mclaughlin labs

mclaughlin labs is a Sioux City, IA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

United Therapeutics

United Therapeutics Corporation is a biotechnology company focused on the development and commercialization of unique products to address the unmet medical needs of patients with chronic and life-threatening conditions. We currently have five approved products on the market, and a long-term mission of providing an unlimited supply of transplantable organs for those who need them! Our employees can be found collaborating across the United States, Europe and Asia. As a group, we are relentless in our pursuit of “medicines for life” and continue to research and develop treatments for cardiovascular and pulmonary diseases, pediatric cancers, and other orphan diseases.